Viking Global Investors Portfolio holdings
AUM
$34.6B
This Quarter Return
+22.42%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$36.4B
AUM Growth
+$36.4B
(+31%)
Cap. Flow
+$3.53B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
39.21%
Holding
111
New
25
Increased
19
Reduced
43
Closed
15
Top Buys
| 1 |
UnitedHealth
UNH
|
$980M |
| 2 |
Visa
V
|
$823M |
| 3 |
Microsoft
MSFT
|
$797M |
| 4 |
AbCellera Biologics
ABCL
|
$776M |
| 5 |
Walt Disney
DIS
|
$774M |
Top Sells
| 1 |
American Express
AXP
|
$680M |
| 2 |
Thermo Fisher Scientific
TMO
|
$605M |
| 3 |
Comcast
CMCSA
|
$465M |
| 4 |
Hilton Worldwide
HLT
|
$457M |
| 5 |
CME Group
CME
|
$388M |
Sector Composition
| 1 | Healthcare | 33.42% |
| 2 | Technology | 26.33% |
| 3 | Financials | 14.82% |
| 4 | Communication Services | 9.86% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Snowflake
SNOW
$79.6B
| $176M | 0.49% | 627,157 -14,283 | -2% | -$4.02M |
|
|
INBX
52
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $175M | 0.48% | 5,305,866 | – | – |
|
53
Air Products & Chemicals
APD
$65.5B
| $174M | 0.48% | +636,600 | New | +$174M |
|
54
Workday
WDAY
$61.6B
| $170M | 0.47% | 707,831 -416,395 | -37% | -$99.8M |
|
55
Las Vegas Sands
LVS
$39.6B
| $168M | 0.46% | 2,826,560 -5,762,752 | -67% | -$343M |
|
56
4D Molecular Therapeutics
FDMT
$288M
| $163M | 0.45% | +3,937,914 | New | +$163M |
|
57
MetLife
MET
$54.1B
| $157M | 0.43% | +3,340,480 | New | +$157M |
|
58
Zentalis Pharmaceuticals
ZNTL
$122M
| $156M | 0.43% | 3,011,284 -1,432,000 | -32% | -$74.4M |
|
59
Bristol-Myers Squibb
BMY
$96B
| $155M | 0.43% | 2,506,793 -682,471 | -21% | -$42.3M |
|
60
Marsh & McLennan
MMC
$101B
| $155M | 0.42% | +1,320,572 | New | +$155M |
|
61
PMV Pharmaceuticals
PMVP
$74.2M
| $145M | 0.4% | 2,364,062 -277,778 | -11% | -$17.1M |
|
62
Match Group
MTCH
$8.98B
| $138M | 0.38% | +914,686 | New | +$138M |
|
63
Becton Dickinson
BDX
$55.3B
| $128M | 0.35% | +511,584 | New | +$128M |
|
64
Darden Restaurants
DRI
$24.1B
| $128M | 0.35% | 1,070,370 -365,687 | -25% | -$43.6M |
|
|
CTLT
65
DELISTED
CATALENT, INC.
CTLT
| $125M | 0.34% | 1,203,641 +17,962 | +2% | +$1.87M |
|
66
Insulet
PODD
$23.9B
| $124M | 0.34% | 483,529 +269,197 | +126% | +$68.8M |
|
67
Royalty Pharma
RPRX
$15.6B
| $114M | 0.31% | 2,287,000 +338,936 | +17% | +$17M |
|
68
Bilibili
BILI
$9.6B
| $112M | 0.31% | +1,311,083 | New | +$112M |
|
69
Equitable Holdings
EQH
$16B
| $99.1M | 0.27% | +3,874,110 | New | +$99.1M |
|
70
Progressive
PGR
$145B
| $88.5M | 0.24% | +895,126 | New | +$88.5M |
|
|
MCFE
71
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $87.6M | 0.24% | +5,251,436 | New | +$87.6M |
|
72
DoorDash
DASH
$105B
| $87.2M | 0.24% | +610,573 | New | +$87.2M |
|
73
PVH
PVH
$4.05B
| $77.7M | 0.21% | 827,892 -934,206 | -53% | -$87.7M |
|
74
CarMax
KMX
$9.21B
| $75M | 0.21% | +794,240 | New | +$75M |
|
|
KNTE
75
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $74.5M | 0.2% | +1,872,023 | New | +$74.5M |
|